Description
For sample adults age 18+ and sample children ages 4-17 who had used guided imagery or progressive relaxation in the past 12 months (RELGIMYR), RELGIMPAIN indicates whether they used guided imagery or progressive relaxation to treat or manage physical pain.
RELGIMPAIN was one of twenty-five variables sponsored by the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) to assess complementary and integrative health (CIH) practices in 2022. Please see THPYART to learn more about the Complementary and Integrative Health content section, including a complete list of CIH variables fielded in the 2022 NHIS.
Related Variables
Please see RELGIMYR to learn more about questions asked about guided imagery and progressive relaxation over time, including a list of related variables fielded in 2022.
